SGRY
Surgery Partners, Inc.NASDAQHealthcare$12.18+0.99%ClosedMarket Cap: $1.58B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.91
P/S
0.48
EV/EBITDA
5.66
DCF Value
$307.52
FCF Yield
12.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.1%
Operating Margin
11.8%
Net Margin
-2.4%
ROE
-4.5%
ROA
-0.9%
ROIC
4.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $885.0M | 24.0% | $110.2M | $-15.0M | $-0.11 | — |
| FY 2025 | $3.31B | 23.1% | $389.5M | $-77.9M | $-0.61 | — |
| Q3 2025 | $821.5M | 23.8% | $105.7M | $-22.7M | $-0.18 | — |
| Q2 2025 | $826.2M | 23.7% | $111.7M | $-2.5M | $-0.02 | — |
| Q1 2025 | $776.0M | 20.9% | $61.9M | $-37.7M | $-0.30 | — |
| Q4 2024 | $864.4M | 27.0% | $127.1M | $-108.5M | $-0.86 | — |
| FY 2024 | $3.11B | 23.9% | $348.8M | $-168.1M | $-1.33 | — |
| Q3 2024 | $770.4M | 23.0% | $60.9M | $-31.7M | $-0.25 | — |
| Q2 2024 | $762.1M | 23.5% | $84.8M | $-15.5M | $-0.12 | — |
| Q1 2024 | $717.4M | 21.6% | $76.0M | $-12.4M | $-0.10 | — |
| Q4 2023 | $735.4M | 26.3% | $101.4M | $-1.0M | $-0.01 | — |
| FY 2023 | $2.74B | 23.6% | $328.0M | $-11.9M | $-0.09 | — |